<label id="xi47v"><meter id="xi47v"></meter></label>

      S.Korean regulator rules Samsung's bio unit breaches accounting rules

      Source: Xinhua| 2018-11-14 17:46:47|Editor: mmm
      Video PlayerClose

      SEOUL, Nov. 14 (Xinhua) -- South Korea's financial regulator ruled on Wednesday that the biopharmaceutical unit of Samsung Group, the country's biggest family-controlled conglomerate, breached accounting rules.

      The Securities and Futures Commission under the Financial Services Commission (FSC) said that its regulatory probe came to a conclusion that Samsung BioLogics "intentionally" violated accounting standards by arbitrarily interpreting and applying the standards.

      Samsung BioLogics, set up in 2011, launched a joint venture, Samsung Bioepis, with the U.S.-based Biogen in 2012.

      The biopharmaceutical unit of Samsung altered the method to evaluate its affiliate, Bioepis, into the mark-to-market valuation in 2015, leading to a net profit of 1.9 trillion won (1.7 billion U.S. dollars) in the year after years of losses.

      Samsung BioLogics has been suspected of committing the fraudulent accounting to help Samsung Electronics Vice Chairman Lee Jae-yong, an heir apparent of Samsung Group, inherit a management control over the entire group from his ailing father Chairman Lee Kun-hee.

      In 2015, Cheil Industries and Samsung C&T merged into Samsung C&T, the currently de-facto holding company of Samsung Group that was evaluated bigger than Cheil Industries, controlled by the Samsung heir at the time.

      By overvaluing Cheil Industries through the overvalued Samsung BioLogics, the Samsung heir was believed to have controlled the de-facto holding company, one of key shareholders of Samsung Electronics.

      The Samsung family has been controlling the Samsung Group with a fraction of shares through cross-shareholding.

      FSC Vice Chairman Kim Yong-beom told a press briefing that the financial regulator will cautiously review whether a separate regulatory probe into Samsung C&T would be needed as Samsung Biologics is an affiliate of Samsung C&T.

      The FSC referred the case to the prosecution office. The Korea Exchange, the country's bourse operator, suspended after-hours trading of Samsung BioLogics right after the FSC ruling.

      TOP STORIES
      EDITOR’S CHOICE
      MOST VIEWED
      EXPLORE XINHUANET
      010020070750000000000000011100001376058721
      主站蜘蛛池模板: 中文字幕成人免费高清在线 | 麻豆亚洲AV永久无码精品久久| 亚洲国产成人久久一区二区三区| 青娱乐免费视频在线观看| 91在线精品亚洲一区二区| 无码精品国产一区二区三区免费 | 亚洲AV无码一区二区二三区软件| 国产在线国偷精品免费看| 亚洲精品狼友在线播放| 搡女人免费免费视频观看| 国产精品亚洲成在人线| 99久久久国产精品免费牛牛四川| 久久精品国产亚洲AV高清热| 精品熟女少妇av免费久久| 亚洲Av无码一区二区二三区| 成人性生交视频免费观看| 久久亚洲精品高潮综合色a片| 国产又大又粗又硬又长免费| a级毛片免费观看在线| 亚洲国产精品无码久久一线| 69精品免费视频| 中中文字幕亚洲无线码| 国产精品黄页在线播放免费| xvideos永久免费入口| 亚洲av网址在线观看| 最新欧洲大片免费在线| 国产亚洲福利精品一区二区| 亚洲人成精品久久久久| 51精品视频免费国产专区| 亚洲AV无码一区二区三区牲色 | 亚洲高清国产拍精品26U| 亚洲人成免费电影| 日韩成人精品日本亚洲| 久久亚洲国产精品一区二区| 免费人成网站在线观看10分钟| 无码天堂亚洲国产AV| 久久久久亚洲av无码专区蜜芽 | 一区二区三区免费精品视频| 亚洲福利在线视频| 成人永久免费高清| 日本在线免费播放|